ALICIA HASLAUER: Open Payments
NPI 1174832612 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,932 in 104 payments from 15 companies in 2025. Trend: 2023 $1,928 · 2024 $1,589 · 2025 $7,932
Speaker / faculty: $5,100Food & beverage: $2,248Travel & lodging: $474Education: $110
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 24 | $6,170 |
| ABBVIE INC. | 24 | $316 |
| GENZYME CORPORATION | 12 | $294 |
| Lilly USA, LLC | 12 | $279 |
| Janssen Biotech, Inc. | 4 | $217 |
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| Incyte Corporation | 6 | $154 |
| Organon LLC | 4 | $89 |
| Amgen Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, EBGLYSS, RINVOQ, OPZELURA, SKYRIZI, TALTZ.
Industry payments across LA — which companies pay providers there.
